Company Announcement no. 17/2010

To: NASDAQ OMX Copenhagen A/S Hørsholm,
Denmark, October 18, 2010


LifeCycle Pharma updates Financial Calendar for 2010 and
announces Financial Calendar for 2011

LifeCycle Pharma A/S (OMX: LCP) issues today an updated financial calendar for
2010 and announces the financial calendar for 2011.

2010
October 28, 2010: Interim Report for the 3rd Quarter - for the period January 1
to
September 30, 2010.
(Changed compared to the previous announced date, November 10, 2010.)
2011
March 1, 2011: Release of Annual Report 2010.
April 12, 2011: Annual General Meeting.
May 10, 2011: Interim Report for the 1st Quarter ‐ for the period January 1 to
March 31, 2011.
August 17, 2011: Interim Report for the 2nd Quarter - for the period January 1
to
June 30, 2011.
November 9, 2011: Interim Report for the 3rd Quarter - for the period January
1 to
September 30, 2011.

For more information, please contact:

LifeCycle Pharma A/S

William J. Polvino Johnny Stilou
President and CEO CFO
Mobile: +1 917 647 9107 Mobile: +45 20 55 38 52
Email: [email protected] Email: [email protected]

Forward looking statement disclaimer
This press release contains certain forward-looking statements, including
statements about the Company's business and a potential offering of shares of
the Company. Such forward-looking statements are based on data, assumptions and
estimates that the Company considers to be reasonable. They are subject to
numerous risks and uncertainties, including matters not yet known to the
Company or not currently considered material by the Company, and there can be
no assurance that anticipated events will occur or that the objectives set out
will actually be achieved. Important factors that could cause actual results
to differ materially from the results anticipated in forward-looking statements
include, among others, shareholder approval of a capital increase, market
conditions and the price of the Company's shares, completion of and the actual
outcome of the Company's ongoing Phase III clinical studies of LCP-Tacro™, as
well as changes in pharmaceutical industry regulation and, in particular,
regulatory approval of pharmaceutical drugs.

181010 lifecycle pharma updates financial calendar for 2010 and announces financial calendar for 2011.pdf